Labetalol is a blood pressure medication used to treat hypertension in both everyday and emergency settings. Its FDA-approved indication is the management of high blood pressure, but it holds a particularly important role in two scenarios: hypertensive crises that require rapid blood pressure reduction, and high blood pressure during pregnancy, where it is considered a first-line treatment.
How Labetalol Works
Most blood pressure medications target one pathway. Labetalol targets two simultaneously. It blocks both alpha-1 and beta receptors in the cardiovascular system, which gives it a dual mechanism that few other drugs in its class share. The beta-blocking action slows the heart rate and reduces how forcefully the heart contracts, lowering the pressure with each beat. The alpha-blocking action relaxes blood vessel walls, allowing them to widen and reducing resistance to blood flow.
This combination produces a meaningful advantage: blood pressure drops without the compensatory spike in heart rate that often happens with other blood pressure drugs. When a medication relaxes blood vessels alone, the body often responds by speeding up the heart to compensate. Labetalol’s beta-blocking component prevents that reflex, making the blood pressure reduction smoother and more controlled. Carvedilol is the only other commonly used beta-blocker that shares this dual alpha- and beta-blocking property.
Chronic High Blood Pressure
In tablet form, labetalol is prescribed for ongoing management of hypertension. The typical starting point is 100 milligrams taken twice daily, with adjustments made over time based on your blood pressure response. It can be used alone or alongside other blood pressure medications.
For routine hypertension management, labetalol is one option among many. Newer drug classes like ACE inhibitors, ARBs, and calcium channel blockers have become more common first choices for most patients. In current practice, labetalol’s oral form tends to be reserved for specific populations where its profile offers a clear benefit, particularly pregnant individuals or people who need the combined alpha- and beta-blocking effect.
Hypertensive Emergencies
Where labetalol really stands out is in urgent, high-stakes situations. When blood pressure spikes to dangerously high levels (typically above 180/120 mmHg with signs of organ damage), it qualifies as a hypertensive emergency, and the priority is bringing those numbers down quickly but in a controlled way. Dropping blood pressure too fast can be just as dangerous as leaving it too high.
Intravenous labetalol is one of the most commonly used drugs in these situations. Its dual mechanism allows for a rapid, dose-dependent decrease in blood pressure, meaning clinicians can titrate the effect precisely. It is also used in blood pressure crises associated with acute ischemic stroke, bleeding in the brain, and subarachnoid hemorrhage, where careful blood pressure control is critical to preventing further damage.
Pregnancy and Preeclampsia
Labetalol is one of the most widely used blood pressure medications during pregnancy and is recommended as a first-line treatment for blood pressure control in preeclampsia by the American College of Obstetricians and Gynecologists (ACOG). Many blood pressure drugs carry risks for fetal development, which narrows the options significantly. Labetalol has a long track record of use in pregnancy with an acceptable safety profile for both the mother and the baby.
Beyond simply lowering blood pressure, labetalol has properties that are specifically helpful in preeclampsia. It preserves blood flow through the uterus and placenta to a greater extent than traditional beta-blockers and other options like methyldopa or nifedipine. Research has also identified additional benefits relevant to preeclampsia: it reduces platelet clumping, lowers levels of a substance called thromboxane that contributes to blood vessel constriction, and may help accelerate fetal lung development.
When blood pressure in pregnancy reaches or exceeds 160/110 mmHg, the risk of stroke becomes a serious concern. In that situation, intravenous labetalol is frequently the drug of choice because it acts quickly while maintaining the blood supply to the baby. This makes it valuable across the spectrum, from managing mild chronic hypertension during pregnancy with oral tablets to treating severe preeclampsia or eclampsia with IV administration in a hospital setting.
Common Side Effects
Because labetalol blocks both alpha and beta receptors, its side effect profile reflects both actions. The most frequently reported side effects are dizziness, fatigue, and nausea. Dizziness is especially common when standing up quickly, because the alpha-blocking component can cause a temporary drop in blood pressure with position changes. This effect tends to be most noticeable in the first few weeks of treatment or after a dose increase.
Other side effects include nasal stuffiness, tingling in the scalp (a distinctive effect reported more with labetalol than other beta-blockers), and digestive symptoms. Some people experience cold hands and feet, which happens because blocking beta-2 receptors can reduce blood flow to the extremities. Sexual dysfunction and difficulty exercising at full capacity are also possible, as with other beta-blockers.
Who Should Not Take Labetalol
Labetalol is not appropriate for everyone. Because it blocks beta-2 receptors in the lungs, it can trigger airway narrowing in people with asthma or severe chronic obstructive pulmonary disease. Unlike “cardioselective” beta-blockers that primarily affect the heart, labetalol’s nonselective beta blockade means it carries a real risk of worsening breathing problems.
People with very slow heart rates, certain types of heart block, or severe heart failure that isn’t well controlled should also avoid labetalol. The beta-blocking action can slow the heart further and worsen these conditions. If you have a history of severe allergic reactions, it’s worth noting that beta-blockers can make those reactions harder to treat with epinephrine, so your provider may choose a different medication.
Stopping labetalol abruptly after taking it regularly can cause a rebound surge in blood pressure and heart rate. If you need to discontinue the medication, the dose is typically tapered down gradually over one to two weeks rather than stopped all at once.
How Labetalol Compares to Other Beta-Blockers
The beta-blocker class includes drugs with quite different properties, and lumping them together can be misleading. Propranolol, for example, blocks both beta-1 and beta-2 receptors but has no alpha-blocking activity, so it lowers blood pressure without the vasodilating benefit. Metoprolol and atenolol are “cardioselective,” meaning they primarily target beta-1 receptors in the heart and are generally safer for people with mild lung disease. Carvedilol is the closest relative to labetalol, sharing both alpha- and beta-blocking properties, though it’s used more often for heart failure than for acute blood pressure crises.
Labetalol’s niche comes down to its speed and versatility. In IV form, it works quickly and predictably for emergencies. In oral form, its dual mechanism makes it a practical choice when you need blood pressure lowering without the heart rate increase that pure vasodilators cause. And in pregnancy, its safety profile and ability to maintain placental blood flow give it an edge that few competitors can match.

